Toripalimab
HCC 25-126
Phase 2 small_molecule active
Quick answer
Toripalimab for Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) is a Phase 2 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Coherus Oncology
- Indication
- Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active